Plain-English translation of NCT06204341 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new way to treat aggressive prostate cancer using radiation therapy that delivers higher doses to the tumor while treating the surrounding lymph nodes. The treatment combines three recent advances in radiation therapy that have each shown promise individually. Researchers want to see if combining them together is safe and works better than current standard treatment.
Recent research has shown that three different improvements to radiation therapy—focusing extra radiation on the main tumor, treating lymph nodes in the pelvis, and using faster radiation schedules—each help men with aggressive prostate cancer. However, no one has yet combined all three approaches together, and doctors want to know if doing so is safe and more effective than treating each part separately.
You likely qualify if…
You likely don't qualify if…
You would receive a special type of radiation therapy that is given over several weeks, with the radiation dose concentrated both on the main prostate tumor and the surrounding lymph nodes, often with minimal or no hormone therapy. The study involves regular follow-up visits to monitor how well the treatment works and watch for any side effects, similar to the standard care you would already receive for this diagnosis. The researchers expect that the additional study burden beyond normal care is minimal, as they are not requiring extra tests or extra appointments beyond what you would typically have anyway.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Netherlands